# Efficacy, Safety and Tolerability of Cadazolid in Subjects With Clostridium Difficile Associated Diarrhea (CDAD)

> **NCT01222702** · PHASE2 · COMPLETED · sponsor: **Actelion** · enrollment: 84 (actual)

## Conditions studied

- Clostridium Difficile Infection

## Interventions

- **DRUG:** Cadazolid
- **DRUG:** Vancomycin
- **DRUG:** Placebo-matching cadazolid
- **DRUG:** Placebo-matching vancomycin

## Key facts

- **NCT ID:** NCT01222702
- **Lead sponsor:** Actelion
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2011-01-25
- **Primary completion:** 2012-10-16
- **Final completion:** 2012-11-12
- **Target enrollment:** 84 (ACTUAL)
- **Last updated:** 2017-06-14


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01222702

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01222702, "Efficacy, Safety and Tolerability of Cadazolid in Subjects With Clostridium Difficile Associated Diarrhea (CDAD)". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT01222702. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*